Literature DB >> 2888030

Receptors mediating the increase in vascular permeability to kinins: comparative studies in rat, guinea-pig and rabbit.

E T Whalley.   

Abstract

The effect of bradykinin (BK) and a variety of kinin analogues and modified kinin fragments were assessed in several models representing the vascular permeability aspect of the inflammatory response. The rank order of potency of various kinin analogues to increase paw volume and skin vascular permeability in rats was sigma-cyclo-(Lys1-Gly6)-BK = sigma-cyclo-kallidin much greater than BK greater than kallidin = methionyl-lysyl-BK much greater than des-Arg9-BK. The same order was seen for skin responses in day 21, rheumatoid-arthritic rats. Mepyramine, 10 mg X kg-1 almost completely inhibited rat skin vascular responses to histamine, had no effect on BK and produced a small but significant inhibition of the responses to both cyclic-kinins. A different rank order of potency for the kinins was produced in both the guinea-pig and rabbit skin; this being kallidin greater than methionyl-lysyl-BK greater than BK much much greater than sigma-cyclo-(Lys1-Gly6)-BK = sigma-cyclo-kallidin greater than des-Arg9-BK. Neither of the cyclic kinins antagonised BK-induced increases in skin vascular permeability in guinea-pig or rabbit. Two modified kinin fragments, D-Pro-Phe-Arg-paranitroaniline and D-Pro-Phe-Arg-heptylamide, which have previously been demonstrated to be putative B2 receptor antagonists on in vitro tissues, enhanced the effect of BK in rat skin and when injected alone produced dose-related increases in skin vascular permeability in normal and rheumatoid-arthritic rats both having approximately half the potency of BK.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888030     DOI: 10.1007/bf00177758

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  Substances which affect capillary permeability.

Authors:  W G SPECTOR
Journal:  Pharmacol Rev       Date:  1958-12       Impact factor: 25.468

2.  A simple precise method for measuring rodent paw volume.

Authors:  J M Hall; C Hallett
Journal:  J Pharm Pharmacol       Date:  1975-08       Impact factor: 3.765

3.  Comparative pharmacological actions of bradykinin and related kinins of larger molecular weights.

Authors:  M L Reis; L Okino; M Rocha e Silva
Journal:  Biochem Pharmacol       Date:  1971-11       Impact factor: 5.858

Review 4.  Pharmacology of kinins: their relevance to tissue injury and inflammation.

Authors:  F Marceau; A Lussier; D Regoli; J P Giroud
Journal:  Gen Pharmacol       Date:  1983

5.  Selective activity of cyclokinins.

Authors:  C F Spraggs; H S Margolius; A W Cuthbert
Journal:  J Pharm Pharmacol       Date:  1983-04       Impact factor: 3.765

6.  Antagonism of the bradykinin induced contractile response of isolated smooth muscle preparations by low molecular weight synthetic chromogenic peptide substrates for serine proteases.

Authors:  J Fareed; G Kindel; H L Messmore; J U Balis
Journal:  Adv Biosci       Date:  1978-07-22

7.  Pharmacological characterization of the vascular permeability enhancing effects of kinins in the rabbit skin.

Authors:  F Marceau; M Knap; D Regoli
Journal:  Can J Physiol Pharmacol       Date:  1981-09       Impact factor: 2.273

Review 8.  Pharmacology of bradykinin and related kinins.

Authors:  D Regoli; J Barabé
Journal:  Pharmacol Rev       Date:  1980-03       Impact factor: 25.468

9.  Cyclic analogue of bradykinin possessing selective and prolonged biological activity.

Authors:  G I Chipens; F K Mutulis; B S Katayev; V E Klusha; I P Misina; N V Myshlyiakova
Journal:  Int J Pept Protein Res       Date:  1981-09

10.  The actions of kinin antagonists on B1 and B2 receptor systems.

Authors:  D Regoli; G Drapeau; P Rovero; S Dion; P D'Orléans-Juste; J Barabé
Journal:  Eur J Pharmacol       Date:  1986-04-09       Impact factor: 4.432

View more
  8 in total

1.  Bradykinin-induced plasma exudation in guinea-pig airways: involvement of platelet activating factor.

Authors:  D F Rogers; S Dijk; P J Barnes
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

2.  Potentiation of the pro-inflammatory effects of bradykinin by inhibition of angiotensin-converting enzyme and aminopeptidase P in rat paws.

Authors:  J Damas; J F Liégeois; W H Simmons
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

3.  Inhibition of bradykinin-induced bronchoconstriction in the guinea-pig by a synthetic B2 receptor antagonist.

Authors:  L S Jin; E Seeds; C P Page; M Schachter
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

4.  Analysis of the receptors mediating vascular actions of bradykinin.

Authors:  E T Whalley; I A Nwator; J M Stewart; R J Vavrek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

5.  A comparison of allergen and polycation induced cutaneous responses in the rabbit.

Authors:  H Jones; W Paul; C P Page
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

6.  Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat.

Authors:  E Cellier; L Barbot; S Iyengar; R Couture
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

7.  The effect of kinin agonists and antagonists on the pain response of the human blister base.

Authors:  E T Whalley; S Clegg; J M Stewart; R J Vavrek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

8.  Anti-inflammatory and analgesic activity of the bradykinin antagonist, icatibant (Hoe 140), against an extract from Porphyromonas gingivalis.

Authors:  T Griesbacher; R L Sutliff; F Lembeck
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.